Sunitinib Hepatotoxicity Risk Assessment

Assess hepatotoxicity risk with sunitinib based on baseline liver function, prior hepatitis exposure, DILI susceptibility factors, and guide dose modification or discontinuation decisions.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Assess hepatotoxicity risk with sunitinib based on baseline liver function, prior hepatitis exposure, DILI susceptibility factors, and guide dose modification or discontinuation decisions

Each component has a specific meaning:

  • Baseline liver function — The baseline liver function recorded for the scenario being assessed.
  • Prior hepatitis exposure — The prior hepatitis exposure recorded for the scenario being assessed.
  • DILI susceptibility factors — The dili susceptibility factors recorded for the scenario being assessed.
  • Guide dose modification or discontinuation decisions — The guide dose modification or discontinuation decisions recorded for the scenario being assessed.

Note: Interpret the sunitinib hepatotoxicity result against the thresholds and context described above.

How to Use

Enter the baseline liver function, prior hepatitis exposure, DILI susceptibility factors, guide dose modification or discontinuation decisions for the scenario you are assessing. Assess hepatotoxicity risk with sunitinib based on baseline liver function, prior hepatitis exposure, DILI susceptibility factors, and guide dose modification or discontinuation decisions. Use the sunitinib hepatotoxicity result to inform your calculation.

Frequently Asked Questions